European guidelines on cardiovascular disease prevention in clinical practice: Executive summary

被引:277
作者
Graham, Ian
Atar, Dan
Borch-Johnsen, Knut
Boysen, Gudrun
Burell, Gunilla
Cifkova, Renata
Dallongeville, Jean
De Backer, Guy
Ebrahim, Shah
Gjelsvik, Bjorn
Herrman-Lingen, Christoph
Hoes, Arno
Humphries, Steve
Knapton, Mike
Perk, Joep
Priori, Silvia G.
Pyorala, Kalevi
Reiner, Zeljko
Ruilope, Luis
Sans-Menendez, Susana
Reimer, Wilma Scholte Op
Weissberg, Peter
Wood, David
Yarnell, John
Zamorano, Jose Luis
机构
来源
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION | 2007年 / 14卷
关键词
D O I
10.1097/01.hjr.0000277984.31558.c4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E1 / E40
页数:40
相关论文
共 227 条
[121]  
Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8
[122]   Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes [J].
Lewis, EJ ;
Hunsicker, LG ;
Clarke, WR ;
Berl, T ;
Pohl, MA ;
Lewis, JB ;
Ritz, E ;
Atkins, RC ;
Rohde, R ;
Raz, I .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :851-860
[123]   THE EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITION ON DIABETIC NEPHROPATHY [J].
LEWIS, EJ ;
HUNSICKER, LG ;
BAIN, RP ;
ROHDE, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (20) :1456-1462
[124]   Inflammation and atherosclerosis [J].
Libby, P ;
Ridker, PM ;
Maseri, A .
CIRCULATION, 2002, 105 (09) :1135-1143
[125]   Psychosocial interventions for patients with coronary artery disease - A meta-analysis [J].
Linden, W ;
Stossel, C ;
Maurice, J .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (07) :745-752
[126]   Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study [J].
Lindholm, LH ;
Ibsen, H ;
Borch-Johnsen, K ;
Olsen, MH ;
Wachtell, K ;
Dahlöf, B ;
Devereux, RB ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Julius, S ;
Kjeldsen, SE ;
Kristianson, K ;
Lederballe-Pedersen, O ;
Nieminen, MS ;
Omvik, P ;
Oparil, S ;
Wedel, H ;
Aurup, P ;
Edelman, JM ;
Snapinn, S .
JOURNAL OF HYPERTENSION, 2002, 20 (09) :1879-1886
[127]   Should β blockers remain first choice in the treatment of primary hypertension?: A meta-analysis [J].
Lindholm, LH ;
Carlberg, B ;
Samuelsson, O .
LANCET, 2005, 366 (9496) :1545-1553
[128]  
Linfante A, 2004, CIRCULATION, V110, P664
[129]   Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture [J].
Lowe, GDO .
BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 (03) :232-250
[130]   Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease [J].
Lowe, GDO .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (08) :1618-1627